The report did not break out the number of overdose deaths, but prior information said that 2014 had the most overdose deaths on record.
Fewer Americans than expected are dying from heart disease and cancer, but these gains are offset by rising numbers of drug overdoses, according to data released Thursday by the CDC.
The top 5 causes of preventable deaths in the United States haven’t changed from 2010 to 2014—they remain, in order, heart disease, cancer, chronic lower respiratory disease, stroke, and a broad category called “unintentional injuries.” The CDC said this last category includes drug overdoses, and it was the only cause with a noticeable spike during the 5-year period.
For 2014, the CDC listed 45,331 accidental deaths as “preventable,” up from 36,836 in 2010. Drug overdoses are not broken out separately, but information released previously by the CDC said there were more overdoses in 2014 than any year on record.
The increase, the report said, “is mostly attributed to an increase in drug poisoning (overdose from prescription and illicit drugs) and falls.” The report offered no details on the causes of falls.
In heart disease and cancer, new treatments and prevention efforts are working. The number of cancer deaths rose only by 15,233 in the 5-year period despite a rapidly aging population. The number of expected cancer deaths fell by 21,234. Anticipated deaths fell slightly in heart disease, stroke, and rose by only 401 in chronic lung disease, about 1.3%; the report said this was not significant.
Accidental deaths, by contrast, stand apart.
“Given the reported increase in potentially preventable deaths from unintentional injuries, these findings might inform the selection and implementation of evidence-based interventions to prevent deaths from injuries such as falls and drug overdoses, based on epidemiological burden,” the report said.
Reference
García MC, Bastian B; Rossen LM, et al. Potentially preventable deaths among the 5 leading causes of death — United States, 2010 and 2014. MMWR Morb Mortal Wkly Rep. 2016;65:1245-1255.
Data Back Neoadjuvant Combo vs Chemo Alone for Early-Stage NSCLC
April 24th 2024For patients with early-stage non–small cell lung cancer (NSCLC), combining neoadjuvant immune checkpoint inhibitors and platinum-based chemotherapy improves 2-year outcomes over chemotherapy alone, suggest findings of an extensive literature review and meta-analysis.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Downward Morbidity, Mortality Trends Discovered Among Patients With Ovarian Cancer, Liver Metastases
April 24th 2024This study indicates a declining trend in morbidity and mortality rates among patients with ovarian cancer and liver metastases, highlighting the efficacy of surgery and chemotherapy in improving survival outcomes.
Read More